What is AMN Healthcare's revenue?

AMN Healthcare (AMN) generated $3.4B in revenue over the trailing twelve months, up 19.9% year over year.

Is AMN Healthcare profitable?

AMN Healthcare is not currently profitable: it reported a net loss of $32.4M over the trailing twelve months, a -0.9% net margin.

What are AMN Healthcare's profit margins?

Gross margin is 27.6% and operating margin is -9.8%, with a -0.9% net margin.

What is AMN Healthcare's earnings per share?

AMN Healthcare's diluted EPS over the trailing twelve months is $-0.86.

Where does AMN Healthcare's income statement data come from?

Every line is extracted from AMN Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

AMN Healthcare AMN Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$2.73B-8.5%	$2.98B-21.3%	$3.79B-27.7%	$5.24B+31.6%
Total cost of revenue	$1.96B-5.2%	$2.06B-18.7%	$2.54B-28.0%	$3.53B+31.9%
Gross profit	$774.06M-15.8%	$919.38M-26.4%	$1.25B-27.2%	$1.72B+31.1%
Gross margin	28.3%-2.5pp	30.8%-2.2pp	33%+0.2pp	32.7%-0.1pp
Selling, general and administrative	$593.02M-6.2%	$632.49M-15.5%	$748.44M-20.1%	$936.58M+28.2%
Compensation and benefits	$30.68M+31.6%	$23.32M+29.4%	$18.02M-40.1%	$30.07M+19.2%
Depreciation and amortization	$152.22M-10.6%	$170.21M+7.7%	$157.99M+17.0%	$135.05M+31.9%
Provision for credit losses	——	$7.08M—	——	$27.62M+2,190%
Other operating expenses	147,205,100,000%-15,050,700,000%	162,255,800,000%+2,703,200,000%	159,552,600,000%-28,765,400,000%	188,318,000,000%+48,570,600,000%
Total operating expenses	$829.53M-18.8%	$1.02B+12.2%	$911.15M-14.8%	$1.07B+28.6%
Operating income	——	-$102.67M-130%	$338.43M-47.7%	$647.1M+35.4%
Interest expense	$45.59M-34.8%	$69.9M+29.1%	$54.14M+34.0%	$40.4M+18.5%
Other income (expense), net	-$2.61M+78.1%	-$11.91M-35.0%	-$8.82M-65.5%	-$5.33M—
Gain (loss) on disposal of assets	$39.21M+22,252%	-$177K—	$0+100%	-$749K-1,540%
Income before income taxes	-$101.06M+41.4%	-$172.57M-161%	$284.29M-53.1%	$606.7M+36.7%
Income tax expense	——	-$25.6M-135%	$73.61M-54.7%	$162.65M+39.6%
Net income	-$95.7M+34.9%	-$146.98M-170%	$210.68M-52.6%	$444.05M+35.6%
Net margin	-3.5%+1.4pp	-4.9%-10.5pp	5.6%-2.9pp	8.5%+0.3pp
Diluted earnings per share	-$2.48+35.8%	-$3.86-172%	$5.33-46.0%	$9.87+44.9%
Basic earnings per share	-$2.48+35.6%	-$3.85-172%	$5.35-46.1%	$9.92+44.4%
Weighted-average shares, diluted	153.9M+0.7%	152.9M-3.6%	158.6M-12.3%	180.9M-5.8%
Weighted-average shares, basic	153.9M+0.8%	152.7M-3.3%	157.8M-12.2%	179.8M-5.7%
Increase in allowance for credit losses and sales credits	——	——	——	$58M+826%
Share-based compensation expense related to employee stock plans	$30.68M+31.6%	$23.32M+29.4%	$18.02M-40.1%	$30.07M+19.2%
Pre-tax stock-based compensation cost	$30.68M+31.6%	$23.32M+29.4%	$18.02M-40.1%	$30.07M+19.2%
Share-Based Payment Arrangement, Expense, after Tax	$22.71M+31.6%	$17.26M+29.4%	$13.34M-40.1%	$22.25M+19.2%
Accounts Receivable, Allowance for Credit Loss, Writeoff	$19.64M+193%	$6.7M+28.3%	$5.22M+105%	$2.55M+80.7%
Amortization of capitalized software and acquired intangible assets	$78.03M-15.9%	$92.77M+3.4%	$89.76M+8.0%	$83.08M+31.8%
Stock options excluded as their inclusion would be anti-dilutive (in shares)	1.8M+26.7%	1.4M+209%	452K+78.7%	253K+216%
Capital investments accrued but not yet paid	——	——	——	——
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	——	——	——	——
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$95.39M+34.9%	-$146.57M-169%	$211.2M-52.4%	$443.41M+35.6%
Federal	$7.62M-62.2%	$20.16M-69.2%	$65.43M-54.9%	$145.22M+47.0%
Foreign	-$47K-117%	$271K-39.9%	$451K—	——
Current State And Local Tax Expense Benefit	$6.62M+31.3%	$5.04M-75.6%	$20.67M-50.9%	$42.05M+23.6%
Federal	-$11.12M+69.7%	-$36.76M-258%	-$10.27M+49.1%	-$20.17M-55.3%
Deferred Foreign Income Tax Expense Benefit	$47K-39.0%	$77K+10.0%	$70K—	——
Deferred taxes	——	-$56.13M-334%	-$12.93M+47.5%	-$24.62M-51.1%
State	-$8.47M+41.1%	-$14.38M-427%	-$2.73M+38.5%	-$4.44M-34.8%
Defined Contribution Plan Cost Recognized	$1.42M-64.7%	$4M-29.4%	$5.67M-81.9%	$31.41M+139%
Effective tax rates	$0.05-64.3%	$0.15-42.7%	$0.26—	——
Income taxes at U.S. statutory rate of 21%	——	——	——	——
Foreign operations	——	——	——	——
Company-owned life insurance policies	-$6.29M-29.6%	-$4.86M-9.6%	-$4.43M—	——
Nondeductible compensation	——	——	——	——
Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment	——	——	——	——
Other	-$0+6.7%	-$0-188%	$0—	——
Nondeductible compensation	$2.74M+96.2%	$1.4M+54.3%	$905K—	——
Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses	——	——	——	——
Sale of disposal group	——	——	——	——
Share-based compensation	——	——	——	——
Company-owned life insurance policies	——	——	——	——
Sale of disposal group	$4.25M—	$0—	$0—	——
Excess tax benefits associated with employee equity plans (in percent)	——	——	——	——
Excess tax benefits associated with employee equity plans	——	——	-$944K—	——
State income taxes – net of federal income tax benefit	——	——	——	——
Changes in unrecognized tax benefits	——	——	——	——
Effective Income Tax Rate Reconciliation Tax Credits Research	——	——	——	——
Share-Based Payment Arrangement, Expense, Tax Benefit	$7.98M+31.6%	$6.06M+29.4%	$4.69M-40.1%	$7.82M+19.2%
Gain (Loss) On Deferred Compensation	-$2.29M—	——	-$465K—	——
Gain (Loss) On Disposal Or Impairment Of Long-lived Assets	-$18.3M-28,054%	-$65K+99.2%	-$8.19M-425%	-$1.56M+42.4%
Income Loss From Continuing Operations Before Income Taxes Domestic	-$101.38M+41.4%	-$173.09M-161%	$283.82M—	——
Income Loss From Continuing Operations Before Income Taxes Foreign	$319K-37.8%	$513K+9.9%	$467K—	——
Federal taxes	$5.27M-75.6%	$21.6M-63.1%	$58.5M—	——
Foreign	$142K-32.4%	$210K-17.0%	$253K—	——
Income Tax Reconciliation Foreign Income Tax Rate Differential	-$65K-127%	$243K-56.3%	$556K—	——
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	-$21.22M+41.4%	-$36.24M-161%	$59.7M-53.1%	$127.39M+36.7%
Effective income tax expense (benefit) attributable to goodwill impairment	$8.27M-54.2%	$18.05M—	$0—	$0—
Nondeductible per-diem paid to drivers	$2.24M+6.4%	$2.11M-29.9%	$3.01M—	$0—
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount	$278K-46.1%	$516K-46.3%	$961K—	——
Share-based compensation	$2.95M+475%	$513K+154%	-$944K+60.4%	-$2.38M-63.2%
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	-$227K-2,622%	$9K-99.0%	$894K-73.2%	$3.34M-16.1%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	-$1.47M+80.1%	-$7.38M-152%	$14.17M-52.3%	$29.71M+23.8%
Changes in unrecognized tax benefits	$2.24M+68.6%	$1.33M-32.1%	$1.96M-39.7%	$3.25M+577%
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount	-$950K-174%	$1.29M-59.4%	$3.17M—	——
Income Taxes Paid, Net	——	$28.15M-64.0%	$78.26M-63.4%	$213.81M+101%
Accounts payable and other current liabilities	-$20.57M+86.7%	-$154.89M—	——	——
Increase (Decrease) in Accounts Receivable	-$49.47M+71.9%	-$176.23M—	——	-$57.92M—
Increase Decrease in Accounts Receivables, Subcontractor	-$22.44M+54.3%	-$49.14M+67.5%	-$151.02M—	——
Increase (decrease) in contract liabilities and current deferred income	——	-$1.34M-140%	-$558K+86.4%	-$4.1M—
Accrued compensation and employee benefits	——	——	-$86.68M—	——
Increase (Decrease) in Income Taxes Receivable	——	$4.07M—	——	$8.88M—
Increase (Decrease) in Other Current Assets	——	$8.53M+303%	-$4.2M—	——
Increase (decrease) in other assets	-$4.87M—	——	$3.18M+1,613%	-$210K+93.9%
Other liabilities	——	$44.43M+534%	-$10.25M+92.2%	-$131.76M-207%
Increase (Decrease) in Prepaid Expense	——	$1.98M+28.1%	$1.54M+103%	-$55.5M-191%
Interest Paid, Capitalized, Investing Activities	$229K-62.2%	$606K-50.7%	$1.23M+74.8%	$703K+101%
Interest Paid, Excluding Capitalized Interest, Operating Activity	$45.11M-26.1%	$61.03M+26.9%	$48.1M+28.2%	$37.52M-1.5%
Non-cash lease expense	-$708K—	——	$1.62M-70.5%	$5.5M+44.4%
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$295.89M-14.0%	-$259.45M-2,518%	$10.73M+102%	-$591.87M-1,596%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	——	-$79.94M+80.6%	-$412.49M-142%	-$170.71M-58.9%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$269.46M-15.9%	$320.42M—	——	$653.73M+114%
Number of reportable segments	——	——	30.0%	30.0%
Number of reporting units	30.0%	3—	——	——
Operating Lease Payments	$9.42M-9.0%	$10.35M+11.2%	$9.31M-30.2%	$13.34M-66.5%
Net unrealized debt securities gains (losses), net of tax	$309K-25.0%	$412K-20.2%	$516K—	——
Other comprehensive income/(loss)	$309K-25.0%	$412K-20.2%	$516K—	——
Other Noncash Income (Expense)	-$2.61M+78.1%	-$11.91M-35.0%	-$8.82M-65.5%	-$5.33M—
Payments For Share Repurchase Program, Excise Tax	$0-100%	$3.7M—	$0—	$0—
Payments of Financing Costs	——	$973K—	——	$0—
Payment, Tax Withholding, Share-Based Payment Arrangement	$2.09M-56.2%	$4.77M-63.7%	$13.15M-12.9%	$15.1M+109%
Payment to Acquire Life Insurance Policy, Investing Activities	$6.38M—	——	$24.9M+15.7%	$21.52M+184%
Payments to Acquire Property, Plant, and Equipment	$35.63M-56.0%	$80.89M-22.0%	$103.69M+36.7%	$75.83M+41.5%
Payments to Acquire Short-Term Investments	$36.15M+2,514%	$1.38M—	$0-100%	$13.15M-78.3%
Proceeds from revolver	$130M+4.0%	$125M-84.7%	$815M—	$0—
Proceeds from disposition of marketable securities and other investments	$10.78M+18.5%	$9.1M-8.0%	$9.89M-31.2%	$14.38M-75.1%
Repayments of Lines of Credit	$315M-16.0%	$375M+5.6%	$355M—	$0—
Payments on debt	$500M—	$0—	$0—	$0—
Revenue From Contract With Customer Excluding Assessed Tax	$2.73B-8.5%	$2.98B-21.3%	$3.79B-27.7%	$5.24B+31.6%
Right Of Use Asset Obtained In Exchange For Operating Lease Liability	——	$5.04M-86.4%	$36.98M—	——
Stock-based compensation	$30.68M+31.6%	$23.32M+29.4%	$18.02M-40.1%	$30.07M+19.2%
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period	——	——	——	——
Shares purchased under employee stock purchase plan	——	——	——	——
Stock repurchase program, authorized cumulative amount	——	——	——	——
Average price paid (in dollars per share)	——	——	——	——
Number of shares purchased (in shares)	——	——	——	——
Treasury stock, shares acquired, average cost per share excluding accelerated share repurchases (in dollars per share)	——	——	——	——
Treasury stock, shares, acquired excluding accelerated share repurchases (in shares)	——	——	——	——
Aggregate purchase price excluding accelerated share repurchases	——	——	$224.74M—	——
Interest expense and penalties, net (benefit)/charge recognized	$2.15M+134%	$920K+66.7%	$552K-33.2%	$826K+2,329%
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions	$0-100%	$978K-47.8%	$1.87M+27.9%	$1.46M+190%
Additions for tax positions of prior years	$2.29M+759%	$266K-45.8%	$491K-75.0%	$1.97M—
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations	$1.16M+139%	$484K-26.1%	$655K+26.7%	$517K-50.9%
Add: dilutive effect of potential common shares (in shares)	$74K-49.7%	$147K—	——	$788K-23.0%
EBIT	-$55.47M+46.0%	-$102.67M-130%	$338.43M-47.7%	$647.1M+35.4%
EBITDA	$101.13M+42.2%	$71.11M-85.8%	$499.36M-36.3%	$784.21M+34.8%
EBITDA	$101.13M+42.2%	$71.11M-85.8%	$499.36M-36.3%	$784.21M+34.8%
EBITDA margin	3.7%+1.3pp	2.4%-10.8pp	13.2%-1.8pp	15%+0.4pp
EBIT	-$55.47M+46.0%	-$102.67M-130%	$338.43M-47.7%	$647.1M+35.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about AMN Healthcare.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AMN Healthcare's revenue?: AMN Healthcare (AMN) generated $3.4B in revenue over the trailing twelve months, up 19.9% year over year.
Is AMN Healthcare profitable?: AMN Healthcare is not currently profitable: it reported a net loss of $32.4M over the trailing twelve months, a -0.9% net margin.
What are AMN Healthcare's profit margins?: Gross margin is 27.6% and operating margin is -9.8%, with a -0.9% net margin.
What is AMN Healthcare's earnings per share?: AMN Healthcare's diluted EPS over the trailing twelve months is $-0.86.
Where does AMN Healthcare's income statement data come from?: Every line is extracted from AMN Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.